Market Research Logo

Ireland Pharmaceuticals and Healthcare Report Q4 2017

Ireland Pharmaceuticals and Healthcare Report Q4 2017

BMI View:

Despite Ireland's robust economic growth, pharmaceutical spending growth will remain muteddue to cost-control measures targeting drug spending over the coming years. The small domestic drugmarket by regional standards will continue to weigh on Ireland's attractiveness to drugmakers seeking tolaunch and commercialise an innovative medicine. Meanwhile, Ireland will remain a top European locationfor multinational pharmaceutical investment, given tax incentives and a skilled workforce. European andglobal economic growth will sustain Ireland-based drug exports growth.

Headline Expenditure Projections

Pharmaceuticals: EUR2.28bn (USD2.52bn) in 2016 to EUR2.25bn (USD2.48bn) in 2017; -1.1% inlocal currency terms and -1.7% in US dollar terms. Forecast in line in local currency terms and revisedslightly upwards in US dollar terms from last quarter.

Healthcare: EUR15.48bn (USD17.12bn) in 2016 to EUR15.91bn (USD17.50bn) in 2017; +2.8% in localcurrency terms and +2.2% in US dollar terms. Forecast broadly in line with last quarter.

Latest Updates

In August 2017, IDA Ireland, the agency responsible for the attraction and development of foreign directinvestment in Ireland, was in discussion with several Indian companies that have a presence in the UKand supply the EU market. They stated that after Brexit, Ireland hopes to see more pharmaceuticalcompanies from India setting up in Ireland to service the European market.


BMI Industry View
Table: Headline Pharmaceuticals & Healthcare Forecasts (Ireland 2015-2021)
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Ireland 2013-2021)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Ireland 2013-2021)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Ireland 2013-2021)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Ireland 2013-2021)
Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Ireland 2013-2021)
OTC Medicine Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Ireland 2013-2021)
Pharmaceutical Trade Forecast
Table: Top 15 Pharmaceuticals and Healthcare Export Companies In 2015
Table: Pharmaceutical Trade Data And Forecasts (Ireland 2015-2021)
Table: Pharmaceutical Trade Data And Forecasts local currency (Ireland 2015-2021)
Industry Risk/Reward Index
Western Europe Pharmaceuticals: Large Market Sizes Boost Attractiveness
Regulatory Review
Intellectual Property Issues
Pricing Regime
Reimbursement Regime
Market Overview
Healthcare Sector
Table: Healthcare Resources (Ireland 2011-2016)
Table: Healthcare Personnel (Ireland 2011-2016)
Table: Healthcare Activity (Ireland 2011-2016)
Research & Development
Clinical Trials
Epidemiology
Competitive Landscape
Research-Based Industry
Table: Multinational Market Activity
Generic Drugmakers
Pharmaceutical Distribution
Demographic Forecast
Table: Population Headline Indicators (Ireland 1990-2025)
Table: Key Population Ratios (Ireland 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Ireland 1990-2025)
Table: Population By Age Group (Ireland 1990-2025)
Table: Population By Age Group % (Ireland 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Table: Indicators - Rationale And Sources

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report